Bachem Bubendorf
Bachem’s Headquarters is our largest GMP hub for Peptide and Oligonucleotide production, advancing development and global supply.
1971
Year founded
1'900+
Employees
Bubendorf: Large-scale production of Peptides and Oligonucleotides
Our Bubendorf site is the company’s largest GMP hub for Peptide and Oligonucleotide manufacturing, combining advanced production, process development, analytics, and global supply. The site also hosts Bachem Holding AG, the headquarters of the Bachem Group since 2003, which is responsible for the company’s global strategy and public relations. With ongoing expansion, it strengthens capacity and reliability for growing market needs.
Key information
Location: Hauptstrasse 144, 4416 Bubendorf, Switzerland
Foundation year: 1971
Employees: 1’900+
Last audit: 2024 (Swissmedic)
Peptide production technology
- Solid Phase Peptide Synthesis (SPPS)
- Liquid Phase Peptide Synthesis (LPPS)
- Tag-Assisted Peptide Synthesis (TAPS)
Oligonucleotide production technology
- Solid Phase Oligonucleotide Synthesis (SPOS)
- Stirred-Bed SPOS (SB SPOS)
- Tag-Assisted Oligonucleotide Synthesis (TAOS)
- Enzymatic ligation (EL)
Further capabilities
Advanced analytical capabilities
Project management
Regulatory support
Supply chain operations
Services on site
Clinical development for Peptides
Commercial manufacturing for Peptides
Manufacturing of cosmetic Peptides
Clinical development for Oligonucleotides
Commercial manufacturing for Oligonucleotides
Manufacturing of Peptides for medical devices
Being part of a team that makes a difference?
Working at Bachem is not just a job, it's a chance to contribute to meaningful projects that impact people's lives. We offer a collaborative and supportive work environment where innovation is encourage and valued.